Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...

Osteoporosis is a medical condition in which new calcium deposits in bone tissue cannot keep up with old bone calcium removal ...

In one of the first studies of its kind, a team of researchers from Keck School of Medicine of USC has found that proteins ...

Implementing opportunistic computed tomography (CT) bone density screening could increase the osteoporosis screening rate, yielding a reduction in medical costs.

The global osteoporosis drugs market size was valued at USD 14.90 billion in 2024 and is projected to reach USD 15.39 billion ...

Should you take a calcium supplement? And if so, how much? Here's what to know about calcium's benefits and some warnings.

To put it another way, women over the age of 45 will spend more days in hospital due to osteoporosis than they will for ...

A new study published in the journal of BMC Gasteroenterology found that patients with the liver cirrhosis had higher risk of ...

The "Osteoporosis_Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of Osteoporosis Clinical ...

The FDA approved Stoboclo and Osenvelt, denosumab biosimilars that could offer more affordable treatment options for ...

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).